US equities
|
SPCX
$167.16
▲+5.16%
NVDA
$236.42
▲+1.06%
MU
$1,064.69
▼-0.95%
TSLA
$378.31
▲+2.08%
MSFT
$525.12
▲+1.47%
SNDK
$1,708.90
▼-0.64%
INTC
$117.41
▼-1.61%
META
$743.37
▲+2.10%
SPCX
$167.16
▲+5.16%
NVDA
$236.42
▲+1.06%
MU
$1,064.69
▼-0.95%
TSLA
$378.31
▲+2.08%
MSFT
$525.12
▲+1.47%
SNDK
$1,708.90
▼-0.64%
INTC
$117.41
▼-1.61%
META
$743.37
▲+2.10%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Beta Bionics, Inc. - Common Stock
(NQ:
BBNX
)
19.20
+0.23 (+1.24%)
Delayed Quote
Updated: 12:23 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beta Bionics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Beta Bionics Q2 Earnings Call Highlights
↗
July 29, 2026
Beta Bionics (NASDAQ:BBNX) reported second-quarter 2026 net sales of $32 million, up approximately 38% from a year earlier, as new patient starts and recurring pharmacy-channel supply revenue supported...
Via
MarketBeat
Topics
Earnings
Beta Bionics (NASDAQ:BBNX) Q2: EPS Beat and Margin Progress Lift Shares 3% After Hours
↗
July 29, 2026
Via
Chartmill
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
July 29, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
July 01, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
June 15, 2026
From
Johnson Fistel, PLLP
Via
Business Wire
Beta Bionics Inc (NASDAQ:BBNX) Beats Q1 2026 Estimates and Raises Full-Year Guidance
↗
April 21, 2026
Via
Chartmill
Beta Bionics Inc (NASDAQ:BBNX) Reports Q4 Earnings Beat and Provides 2026 Revenue Guidance
↗
February 17, 2026
Via
Chartmill
Topics
Earnings
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
June 03, 2026
From
Johnson Fistel, PLLP
Via
Business Wire
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
June 02, 2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print
From
Beta Bionics, Inc.
Via
GlobeNewswire
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
June 01, 2026
From
Robbins LLP
Via
Business Wire
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
May 21, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
↗
May 15, 2026
This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions.
Via
The Motley Fool
Topics
Regulatory Compliance
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
↗
May 15, 2026
Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors.
Via
The Motley Fool
Topics
Regulatory Compliance
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
↗
May 15, 2026
Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.
Via
The Motley Fool
Topics
Regulatory Compliance
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
↗
May 13, 2026
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company’s first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales...
Via
MarketBeat
Beta Bionics to Present at the Bank of America Securities Health Care Conference
April 27, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics BBNX Q1 2026 Earnings Transcript
↗
April 21, 2026
Beta Bionics BBNX Q1 2026 Earnings Transcript
Via
The Motley Fool
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
April 21, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
March 31, 2026
Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic Pancreas
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
March 30, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
March 24, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)
March 19, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
March 13, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
March 06, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
March 03, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
February 26, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
February 19, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
February 19, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Beta Bionics (BBNX) Q4 2025 Earnings Transcript
↗
February 17, 2026
Beta Bionics (BBNX) Q4 2025 Earnings Transcript
Via
The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
February 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
